Technical difficulties
NASDAQ delisting, raising finance with share price so low, they could easily take the slow road and self finance. If they have revenue they have Silicon Bank.
I don't see bad management, I see an approved product with old tech and poor targeting. Maybe too hard for anyone but SSH does know the HF landscape, including neurohormonal which is positive for Class3 Aquadex patients (not class 4) and does have considerable tech know how plus a new regulatory executive hire after the Aquadex purchase (from memory).
- Forums
- ASX - By Stock
- SHC
- Short Interest
Short Interest, page-6
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NVA
Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
IGO
IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity